Antidepressants do help with anxiety, and they are the most commonly prescribed long-term medication for anxiety disorders. About 60 to 75% of people with generalized anxiety disorder respond to these medications, compared to 40 to 60% of people taking a placebo. The benefit is real, but it’s moderate rather than dramatic, and there are important details about timing, side effects, and what to realistically expect.
How Effective Are They, Really?
The two main classes of antidepressants used for anxiety are SSRIs (like sertraline and escitalopram) and SNRIs (like venlafaxine and duloxetine). Both are considered first-line treatments for generalized anxiety disorder, social anxiety disorder, and panic disorder. A meta-analysis of 33 trials involving over 10,000 participants found that antidepressants produced a modest but statistically significant improvement over placebo. In practical terms, for every three or four people treated, roughly one will improve because of the medication itself rather than the placebo effect.
That gap between the medication group and the placebo group matters. The high placebo response rate (up to 60%) doesn’t mean the drugs are useless. It means that both the medication and the structured attention of a clinical trial help, and the medication adds a meaningful extra layer on top. Still, antidepressants are not a guaranteed fix. Roughly one in four people won’t respond to their first medication, and finding the right one can involve some trial and error.
Why an “Antidepressant” Works for Anxiety
The name is misleading. SSRIs and SNRIs increase the availability of serotonin in the brain, and serotonin plays a central role in regulating fear and threat responses, not just mood. These medications change activity in the brain’s fear-processing center, dampening the exaggerated alarm signals that drive anxiety. Specifically, increased serotonin activates certain inhibitory cells that quiet overactive fear circuits. Over time, this recalibrates how your brain evaluates threats, so everyday situations that used to feel dangerous stop triggering the same intense response.
This recalibration is why the medications take time to work and why the effect is fundamentally different from a sedative or anti-anxiety pill that simply numbs the nervous system.
How Long Before You Feel Better
Most people notice some improvement within one to two weeks, but antidepressants can take up to eight weeks to reach their full effect. In clinical trials of venlafaxine for anxiety, significant reductions in anxiety scores appeared as early as week one at higher doses and by week two at lower doses. But that early improvement is just the beginning. The full therapeutic benefit builds gradually.
This timeline creates a frustrating window. You’re taking a new medication, possibly dealing with side effects, and the anxiety hasn’t budged yet. Many people quit during this period, which is one of the biggest reasons treatment fails. Sticking with the medication through the first month, assuming side effects are tolerable, gives it the best chance to work.
The Paradox: Anxiety May Get Worse First
One of the most unsettling things about starting an antidepressant for anxiety is that it can temporarily make anxiety worse. This is called the jitteriness syndrome, and published rates range widely, from about 4% to 65% of people starting treatment. A well-designed study of fluoxetine found it in 28% of patients compared to 17% on placebo, suggesting the drug itself is responsible for at least some of the increase.
Symptoms typically appear in the first week: heightened nervousness, restlessness, irritability, and trouble sleeping. For most people, this spike is short-lived. Several studies found it resolves within five to thirteen days, with symptoms peaking in week one and fading after week two. However, some research has found that insomnia and anxiety can persist at elevated levels for three months in a subset of patients, so the experience varies. Knowing this pattern exists can make it easier to ride out those early days rather than assuming the medication is making things worse permanently.
Antidepressants vs. Benzodiazepines
Benzodiazepines (like alprazolam and lorazepam) work faster and produce a slightly larger short-term reduction in anxiety symptoms than antidepressants. In head-to-head comparisons, benzodiazepines showed a moderate effect size of 0.50, versus 0.34 for antidepressants. So why aren’t benzodiazepines the default?
The trade-off is dependence and tolerance. Benzodiazepines can become habit-forming within weeks, and stopping them after regular use causes withdrawal symptoms that can mimic or worsen anxiety. Clinical guidelines no longer recommend them as standalone long-term treatment. They’re now reserved for short-term use or as a bridge while waiting for an antidepressant to take effect. Antidepressants are slower to start but sustainable for months or years without the same dependence risk.
Combining Medication With Therapy
Antidepressants work better when paired with cognitive behavioral therapy (CBT). In a large trial of patients with anxiety, 81% responded to the combination of an SSRI plus CBT, compared to 55% who responded to the SSRI alone. That’s a substantial difference. Across multiple studies, adding CBT to medication was associated with roughly 27% additional improvement over medication by itself.
This makes intuitive sense. The medication quiets the brain’s overactive alarm system, while therapy teaches you new ways to evaluate and respond to the situations that trigger anxiety. The medication creates a calmer baseline from which you can actually practice and absorb those new skills. Neither approach addresses every piece of the puzzle on its own.
What Happens When You Stop
Discontinuation is where many people run into trouble. A major trial published in the New England Journal of Medicine followed patients who had been stable on antidepressants and randomly assigned them to either continue or taper off. Within a year, 56% of those who stopped their medication relapsed, compared to 39% of those who stayed on it. That’s a meaningful gap, though it also reveals that a substantial number of people do fine after stopping.
The challenge is predicting which group you’ll fall into. People with longer histories of anxiety, more severe symptoms, or previous relapses tend to be at higher risk. Most guidelines suggest staying on medication for at least 12 months after symptoms are well-controlled before considering a taper, and any reduction should be gradual rather than abrupt to minimize withdrawal effects and rebound anxiety.
When the First Medication Doesn’t Work
If one SSRI or SNRI doesn’t produce enough relief after a full trial of eight weeks at an adequate dose, switching to a different one is the standard next step. Because SSRIs and SNRIs are so similar in overall effectiveness, individual brain chemistry often determines which specific drug works best for a given person.
Beyond SSRIs and SNRIs, other options exist. Mirtazapine, an antidepressant that works through different brain pathways, has shown effectiveness comparable to older tricyclic antidepressants and may be particularly helpful when anxiety is accompanied by insomnia, since it has a sedating quality. Buspirone, a non-antidepressant anxiety medication, is effective for generalized anxiety at adequate doses but doesn’t help much with panic disorder or obsessive-compulsive disorder. For treatment-resistant cases, some guidelines recommend adding a low dose of a second medication as an augmentation strategy rather than replacing the antidepressant entirely.
The broader point is that not responding to one antidepressant doesn’t mean medication can’t help you. It often takes adjustments to find the right fit, and the process, while frustrating, leads to meaningful improvement for the majority of people who persist with it.